Index of authors for abstracts accepted at BOPSS 2018, Dublin. Click here for full abstract listings.
The numbers refer to abstracts of submitted free papers. First authors are indicated in bold.
Abstracts starting with number 1 are presented on Thursday, click here to view detailed schedule
Abstracts starting with number 2 are presented on Friday, click here to view detailed schedule
Abstracts starting with number 3 & 4 refer to ePoster presentations.
Please note that this list is auto-generated from the abstract submissions based on surnames, so differences in the initials entered can lead to duplicate entries and where authors share surnames then the abstract details should be checked by clicking on the abstract number to verify the exact author.
This is a list of accepted authors and presentations. It assumes that all accepted will attend and present
| Title | Adenoid cystic carcinoma of the lacrimal gland: Survival outcomes from a Dutch Orbital Centre |
| Submitted by | Varajini Joganathan |
| Abstract ID | 18-114 |
| Review Result | rapid fire presentation |
| Abstract Number | 201 |
| Purpose | To evaluate the outcomes of patients with adenoid cystic carcinoma of the lacrimal gland (ACCLG) treated at an orbital centre in Amsterdam. |
| Methods | Retrospective case series of 19 consecutive cases of ACCLG presenting at a tertiary care centre, between 1980 and 2000. Factors predictive of overall survival were identified by statistical analysis. Clinical presentation, management, histological findings and its impacts were reviewed for all patients. Overall survival was measured from the date of initial diagnosis. |
| Results | The 19 patients with a median age of 42 years (range: 32-66 years). The median follow up period was 11 years (range, 5 to 13 years). A majority of 17 patients had stage > T3 tumour. Treatment modalities: Orbitotomy, tumour resection and radiation therapy (RT) in 17 patients; Exenteration and RT in 1 patient and chemotherapy (no surgery or RT) in 1 patient Of all patients receiving RT, 6 patients received external beam radiotherapy (EBRT) and 12 patients received Brachytherapy (BRT). Survival rates Observed at 5 and 10 years were 73.7% and 47.9% respectively. Five patients died of local recurrence of tumour, 7 patients died of metastatic disease. Distant metastasis significantly affected patient survival. Histological subtype had no significant correlation with survival outcomes in our series. Four patients had histologic evidence of perineural invasion. |
| Conclusion | Tumor excision with adjuvant radiotherapy in our cohort, achieves comparable disease free survival rate compared to traditional, orbital exenteration for lacrimal gland adenoid cystic carcinoma. Distant metastasis proved to be a significant predictor of patient survival. |
